US · Healthcare · Medical Devices
EPS came in at -0.14 against a street estimate of -0.17 — a beat of 17.6%.
Analysts rate Inogen Inc a buy (2 buy, 0 hold, 1 sell out of 3) with an average price target of $12.00.
| Fund | Stake |
|---|---|
| BlackRock Inc | 6.21% |
| Armistice Capital, LLC | 4.52% |
| Acadian Asset Management LLC | 4.08% |
| Vanguard Capital Management, LLC | 3.91% |
| Ameriprise Financial Inc | 3.24% |
| Dafna Capital Management LLC | 3.18% |
| Point72 Asset Management, L.P. | 2.42% |
| Geode Capital Management, LLC | 2.31% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Inogen Inc — free to start.
Google PlayApp StoreData updated 2026-09-18.